Cen Juan, Zheng Beibei, Bai Rubing, Zhang Li, Zhang Feng, Zhang Xia
College of Pharmacy, Henan University, Kaifeng, People's Republic of China.
Key Laboratory of Natural Medicine and Immune Engineering, Henan University, Kaifeng, People's Republic of China.
Oncotarget. 2017 Apr 20;8(41):69465-69476. doi: 10.18632/oncotarget.17287. eCollection 2017 Sep 19.
Triterpenoids from the have been shown cytotoxicity on a broad spectrum of human tumor cells. In the present study, we extracted triterpenoids AA-5 (1) and AA-6 (2) from stems of , and studied their cytotoxicity in multidrug resistant (MDR) MCF-7/ADM cells. After 48 h treatment, AA-5 (1) and AA-6 (2) significantly increased mitochondrial-mediated apoptosis by enhancing reactive oxygen species (ROS) with depressed mitochondrial membrane potential and caspase-9 activities. The drug efflux transporter P-glycoprotein (P-gp) and the intracellular antioxidant systems, involving Glutathione S-Transferase π, Glutathione and heme oxygenase-1, were also inhibited via the ROS-depressed Akt/NF-E2-related factor 2 pathway. Furthermore, 2 h-treatment of AA-6 (2) at non-toxic concentrations exhibited MDR reversal effects with no alteration on P-gp expression but increased drug accumulation ability. AA-6 alos demonstrated synergetic effects with classic anti-tumor agents. Moreover, computational modeling studies showed that AA-6 (2) might bind to the modulator site on P-gp and act as an inhibitor, not a substrate of P-gp. Therefore, AA-5 (1) and AA-6 (2) may be effective anti-tumor and reversal agents for the further development of therapeutics against MDR breast cancer.
从[具体植物名称未给出]中提取的三萜类化合物已被证明对多种人类肿瘤细胞具有细胞毒性。在本研究中,我们从[具体植物名称未给出]的茎中提取了三萜类化合物AA - 5(1)和AA - 6(2),并研究了它们对多药耐药(MDR)MCF - 7/ADM细胞的细胞毒性。处理48小时后,AA - 5(1)和AA - 6(2)通过增强活性氧(ROS)、降低线粒体膜电位和半胱天冬酶 - 9活性,显著增加了线粒体介导的细胞凋亡。药物外排转运蛋白P - 糖蛋白(P - gp)以及涉及谷胱甘肽S - 转移酶π、谷胱甘肽和血红素加氧酶 - 1的细胞内抗氧化系统,也通过ROS抑制的Akt/NF - E2相关因子2途径受到抑制。此外,在无毒浓度下对AA - 6(2)进行2小时处理表现出多药耐药逆转作用,对P - gp表达无改变,但增加了药物积累能力。AA - 6还与经典抗肿瘤药物表现出协同作用。此外,计算模型研究表明,AA - 6(2)可能与P - gp上的调节剂位点结合并作为抑制剂起作用,而不是P - gp的底物。因此,AA - 5(1)和AA - 6(2)可能是用于进一步开发抗多药耐药乳腺癌治疗药物的有效抗肿瘤和逆转剂。